Status | Study |
Active, not recruiting |
Study Name: Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial Condition: Glycogen Storage Disorder Type 1 Hypoglycemia Date: 2014-06-24 Interventions: Dietary Supplement: Glycosade Other Name: Modified starch |
Completed |
Study Name: Study of Glycogen Storage Disease Expression in Carriers Condition: Glycogen Storage Disease Date: 2014-02-05 Interventions: Genetic: Glycogen Storage Disease markers Blood and urine tests will be performed on all groups to measu |
Completed |
Study Name: Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch Condition: Glycogen Storage Disease Type IA Glycogen Date: 2014-01-31 Interventions: Dietary Supplement: Glycosade |
Completed |
Study Name: Overnight Feeding Study in Glycogen Storage Disease Type 1 Condition: Glycogen Storage Disease Type 1 (GSD 1) Date: 2013-10-08 Interventions: Other: overnight nutrition regime Patients receive the specified overnight nutrition regimen |
Completed |
Study Name: Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease Condition: Inflammatory Bowel Disease Glycogen Storage Disease Type Ia Date: 2013-05-10 Interventions: Other: Glycogen Storage Disease type Ia patients The participants will have one blood draw for this stud |
Withdrawn |
Study Name: High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease Condition: Glycogen Storage Disease Type II Date: 2012-08-01 Interventions: Other: High Protein and Exercise Therapy along-with Nocturnal Enteral Feeding |
Completed |
Study Name: Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies. Condition: Pompe Disease Late-Onset Glycogen Storage Disease Type II GSD I Date: 2008-10-02 Interventions: Biological: Myozyme 30 mg/kg qow f and 40 mg/kg qow |
Completed |
Study Name: Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies Condition: Pompe Disease Infantile-Onset Glycogen Storage Disease Type II Date: 2008-09-30 Interventions: Biological: Myozyme 10 mg/kg or 20 mg/kg qw OR 20 mg/kg or 40 mg/kg qow |
Completed |
Study Name: Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 Condition: Glycogen Storage Disease Type II Date: 2005-08-01 Interventions: Biological: Myozyme 20 mg/kg qow or 40 mg/kg qow Oth |
Completed |
Study Name: A Prospective, Observational Study in Patients With Late-Onset Pompe Disease Condition: Glycogen Storage Disease Type II Date: 2004-02-10 |